Discover 185 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Vermont offers a variety of opportunities for both healthy volunteers interested in taking part in paid studies and those with specific health conditions. Research centers in Burlington, Rutland, and Montpelier are actively recruiting, granting access to cutting-edge therapies and innovative medical care.
Filter
1
Filter results
Results: 185
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
for
Alzheimer Disease
Location: South Dartmouth MA, Newton MA, Springfield MA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011732
Phase3, Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Saint Johnsbury VT, Lebanon NH, Lake Success NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase3, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Guilford CT, New Haven CT, Quebec City, Bay Shore NY,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: New Britain CT, Staten Island NY, Colchester VT,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06878261
Phase3, Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
for
Failed or Difficult Intubation, Sequela, Intubation; Difficult,
Location: Boston MA, Providence RI, Springfield MA, New Haven CT,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT02493478
Recruiting
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
for
Recurrent Pericarditis
Location: Boston MA, New York NY, Burlington VT, Montreal,
Sponsor: Cardiol Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06708299
Phase3, Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
for
Rheumatic Joint Disease
Location: Halifax, Boston MA, Providence RI, Hartford CT,
Sponsor: Duke University
Sex: All
Age: 0 - 21
Code: NCT02418442
Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia,
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554406
Phase2, Recruiting
Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD
for
Opioid Use Disorder, Posttraumatic Stress Disorder
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 18+
Code: NCT06288711
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Boston MA, Stoneham MA, Westerly RI, Waterford CT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase3, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Location: Boston MA, The Bronx NY, Hackensack NJ, Burlington VT,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0 - 1
Code: NCT05685745
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
for
Crohn's Disease
Location: Halifax, Hartford CT, New York NY, Burlington VT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 2 - 17
Code: NCT05509777
Phase3, Recruiting
Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy
for
Breast Cancer
Location: Brooklyn, NY, Burlington VT
Sponsor: University of Vermont
Sex: Female
Age: 18+
Code: NCT01612247
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Westbrook ME, Worcester MA, Hartford CT, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer